SkyDance Vascular

SkyDance Vascular, Inc. is dedicated to the development of peripheral intravenous catheters (PIV). The Osprey Catheter Delivery System, launching in 2021, aims to reduce the number of known complications caused by traditional catheter designs. The company’s patent-pending design introduces four significant improvements, including:1. Skin Avoidance Technology, as the catheter never touches the skin, minimizing the risk of infection.2. Only Bevel Technology, ensuring the needle does not pierce the initial entry point, reducing the risk of phlebitis and infiltration.3. Contoured Directional Flow designed for more efficient fluid delivery while lowering the risk of chemical and mechanical damage, providing more effective drug delivery.4. Passive Needle Retraction, where the needle automatically retracts into the housing so clinicians won’t get stuck.SkyDance is composed of experienced industry veterans with expertise in developing, commercializing, and scaling businesses. The executive team has a successful track record in selling startups within the vascular access space, promising strong returns for investors.